Study suggests that a newly developed topical endocannabinoid membrane transporter inhibitor can  minimized allergic flares and pruritus in dogs with atopic dermatitis. 

A study aimed to test the effects of a 1% solution of a topical endocannabinoid membrane transporter inhibitor on pruritus and dermatitis in atopic dermatitis. Nineteen Beagles that had confirmed allergy to dust mites were given treatment twice a day and evaluated twice weekly for 28 days. Significant decrease on pruritus with treatment and no adverse effects were noted. 

Read more by clicking on the link below:

Double blinded, vehicle controlled, crossover study on the efficacy of a topical endocannabinoid membrane transporter inhibitor in atopic Beagles.